Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort
暂无分享,去创建一个
F. Tubach | A. Dupuy | M. Richard | E. Sbidian | O. Chosidow | M. Beylot-Barry | C. Paul | E. Mahé | M. Viguier | H. Bachelez | P. Joly | D. Jullien | N. Bénéton | Hugo Arlégui | T. Bettuzzi | H. Arlegui | É. Sbidian | M. Beylot‐Barry